Rahman MM, Rumzhum NN, Hansbro PM, Morris JC, Clark AR, Verrills NM and Ammit AJ (2016) Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells. Cell Signal 28(4):325-34
Ross EA, Smallie T, Ding Q, O’Neil JD, Cunliffe HE, Tang T, Rosner DR, Klevernic I, Morrice NA, Monaco C, Cunningham AF, Buckley CD, Saklatvala J, Dean JL and Clark AR (2015) Dominant suppression of inflammation via targeted mutation of the mRNA destabilizing protein tristetraprolin. J Immunol 195(1):265-76
Smallie T, Ross EA, Ammit AJ, Cunliffe HE, Tang T, Rosner DR, Ridley ML, Buckley CD, Saklatvala J, Dean JL and Clark AR (2015) Dual-specificity phosphatase 1 and tristetraprolin cooperate to regulate macrophage responses to lipopolysaccharide. J Immunol 195(1):277-88
Rahman MM, Rumzhum NN, Morris JC, Clark AR, Verrills NM and Ammit AJ (2015) Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin. Nature Scientific Reports 5:10063
Prabhala P, Bunge K, Rahman MM, Ge Q, Clark AR and Ammit AJ (2015) Temporal regulation of cytokine mRNA expression by tristetraprolin: dynamic control by p38 MAPK and MKP-1. Am J Physiol Lung Cell Mol Physiol 308(9):L973-80
Misharin AV, Cuda CM, Saber R, Turner J, Gierut AK, Haines GK, Berdnikov S, Filer A, Clark AR, Buckley CD, Mutlu GM, Budinger GRS and Perlman H (2014) Non-classical Ly6C- monocytes drive the development of inflammatory arthritis in mice. Cell Reports 9(2):591-604
Pinart M, Hussain F, Shirali S, Li F, Zhu J, Clark AR, Ammit AJ and Chung KF (2014) Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury. Eur J Pharmacol 744:108-14
Iqbal MB, Johns M, Liu Y, Yu S-C, Hyde GD, Laffan MA, Marchese FP, Cho SH, Clark AR, Gavins FN, Blackshear PJ, Wollard KJ, Mackman N, Dean JLE, Boothby M and Haskard DO (2014) PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression. Blood 124:3646-55
Clark AR and Dean JLE (2012) The p38 MAPK pathway in rheumatoid arthritis: a sideways look. Open Rheumatology Journal 6:209-19
Ahasan M, Hardy R, Jones C, Kaur K, Hassan-Smith Z, Bénézech C, Caamaňo JH, Hewison M, Lavery G, Rabbitt EH, Clark AR, Buckley CD, Raza K, Stewart PM and Cooper MS (2012) Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells. Arthritis and Rheumatism 64(7):2404-13
Clark AR and Belvisi MG (2012) Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol Ther 134(1):54-67
Vattakuzhi Y, Abraham S, Freidin A, Clark AR* and Horwood N* (2012) Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis. Arthritis and Rheumatism 64(7):2201-10 *equal contributors
Turpeinen T, Nieminen R, Taimi V, Heittola T, Sareila OT, Clark AR, Moilanen E and Korhonen R (2012) Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinase. Mediators of Inflammation 127587
Joanny E, Ding Q, Gong L, Kong P, Saklatvala J and Clark AR (2012) Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1. B J Pharmacol 165(4b):1124-36
View all publications in research portal